Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway-Reference-Cited by-同舟云学术

Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway

Published:2022-05-02 Issue:5 Volume:13 Page:13906-13918
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Dai Yitian¹²,Liu Yuping³,Li Jingyi⁴,Jin Mingming²,Yang Hao²^ORCID,Huang Gang¹²

Affiliation:

1. Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, China

2. Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China

3. Beijing University of Chinese Medicine, Beijing, China

4. Qiqihar Medical University, Qiqihar Heilongjiang, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2086378

Reference45 articles.

1. Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer

2. Prevention and management of lung cancer in China

3. Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer

Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review

5. Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tectorigenin Inhibits Glycolysis-induced Cell Growth and Proliferation by Modulating LncRNA CCAT2/miR-145 Pathway in Colorectal Cancer;Current Cancer Drug Targets;2024-10

2. Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments;Biomedicine & Pharmacotherapy;2024-09

3. Shikonin protects skin cells against oxidative stress and cellular dysfunction induced by fine particulate matter;Cell Biology International;2024-08-21

4. Systematic bioinformatics analysis reveals the role of shikonin in blocking colon cancer progression by identifying senescence-induced genes;Frontiers in Pharmacology;2024-08-12

5. Shikonin inhibits the growth of anaplastic thyroid carcinoma cells by promoting ferroptosis and inhibiting glycolysis;Heliyon;2024-07